Luis G. Paz-Ares, MD, PhD, on Managing Immune-Related Adverse Events Associated With Checkpoint Inhibitor Therapy

Posted: Wednesday, October 18, 2017

How do you work with non-oncology specialists who must collaborate with you to manage patients’ complications from checkpoint inhibitors?